Susquehanna International Group
DMK

Susquehanna International Group’s DMK Pharmaceuticals Corporation Common Stock DMK Stock Holding History

Susquehanna International Group’s Portfolio DMK Stock Details DMK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-20,237
Closed -$14.2K – 13811
2023
Q4 		$14.2K Buy
+20,237
New +$11.7K ﹤0.01% 12027
2023
Q2 		– Sell
-315
Closed -$1.35K – 13498
2023
Q1 		$2.56K Buy
315
+116
+58% +$1.54K ﹤0.01% 12352
2022
Q4 		$2.36K Sell
199
-2,470
-93% -$28.2K ﹤0.01% 12119
2022
Q3 		$37K Buy
+2,669
New +$68.9K ﹤0.01% 12374
2022
Q2 		– Sell
-2,485
Closed -$77.6K – 14270
2022
Q1 		$99K Sell
2,485
-4,349
-64% -$187K ﹤0.01% 11927
2021
Q4 		$289K Sell
6,834
-12,845
-65% -$801K ﹤0.01% 10584
2021
Q3 		$1.34M Buy
19,679
+7,009
+55% +$513K ﹤0.01% 6799
2021
Q2 		$976K Buy
12,670
+1,736
+16% +$106K ﹤0.01% 7842
2021
Q1 		$719K Buy
10,934
+7,054
+182% +$549K ﹤0.01% 8588
2020
Q4 		$132K Buy
3,880
+112
+3% +$4.98K ﹤0.01% 10338
2020
Q3 		$207K Buy
3,768
+3,597
+2,104% +$213K ﹤0.01% 9396
2020
Q2 		$6K Sell
171
-118
-41% -$4.04K ﹤0.01% 10002
2020
Q1 		$7K Buy
289
+99
+52% +$4.2K ﹤0.01% 10083
2019
Q4 		$9K Sell
190
-535
-74% -$25.9K ﹤0.01% 9559
2019
Q3 		$36K Sell
725
-981
-58% -$70.5K ﹤0.01% 9859
2019
Q2 		$155K Sell
1,706
-998
-37% -$121K ﹤0.01% 9345
2019
Q1 		$399K Buy
2,704
+1,431
+112% +$277K ﹤0.01% 6703
2018
Q4 		$201K Sell
1,273
-7,531
-86% -$1.44M ﹤0.01% 7745
2018
Q3 		$2.16M Buy
8,804
+7,705
+701% +$1.82M ﹤0.01% 3850
2018
Q2 		$246K Sell
1,099
-267
-20% -$71.5K ﹤0.01% 8225
2018
Q1 		$335K Sell
1,366
-3,867
-74% -$1.01M ﹤0.01% 7438
2017
Q4 		$1.61M Buy
5,233
+83
+2% +$27.3K ﹤0.01% 4321
2017
Q3 		$1.88M Buy
5,150
+4,179
+430% +$1.48M ﹤0.01% 4029
2017
Q2 		$353K Sell
971
-250
-20% -$74.9K ﹤0.01% 7285
2017
Q1 		$363K Sell
1,221
-123
-9% -$31K ﹤0.01% 7048
2016
Q4 		$296K Buy
1,344
+303
+29% +$60.8K ﹤0.01% 7997
2016
Q3 		$250K Buy
1,041
+355
+52% +$73.8K ﹤0.01% 7224
2016
Q2 		$134K Buy
686
+452
+193% +$208K ﹤0.01% 7881
2016
Q1 		$100K Sell
234
-116
-33% -$41.4K ﹤0.01% 8429
2015
Q4 		$132K Buy
350
+187
+115% +$58.6K ﹤0.01% 8740
2015
Q3 		$45K Sell
163
-71
-30% -$19.8K ﹤0.01% 9390
2015
Q2 		$69K Sell
234
-58
-20% -$17.5K ﹤0.01% 9797
2015
Q1 		$80K Sell
292
-2
-0.7% -$864 ﹤0.01% 9034
2014
Q4 		$127K Buy
294
+118
+67% +$37.5K ﹤0.01% 9094
2014
Q3 		$58K Sell
176
-67
-28% -$19.6K ﹤0.01% 9196
2014
Q2 		$82K Buy
+243
New +$95.4K ﹤0.01% 9475

Other funds holding DMK

CPA
Clear Point Advisors Melville, New York $129M AUM 12.02% 1-Year Est. Return
OPTFSNA
Old Point Trust & Financial Services N A Newport News, Virginia $311M AUM 24.14% 1-Year Est. Return

Susquehanna International Group's DMK Position: Q1 2024 in Review

Susquehanna International Group sold out of DMK Pharmaceuticals Corporation Common Stock (DMK) in Q1 2024, closing a stake of 20,237 shares — an estimated $14.2K sold.

Susquehanna International Group first reported a position in DMK in Q2 2014 and held it in 36 quarters. The position peaked at $2.16M in Q3 2018. 3 funds tracked by Wall St. Rank hold DMK as of Q1 2024.

  • Susquehanna International Group reported no remaining DMK Pharmaceuticals Corporation Common Stock position as of Q1 2024 after selling out during the quarter.
  • Susquehanna International Group sold 20,237 DMK Pharmaceuticals Corporation Common Stock shares in Q1 2024, an estimated $14.2K.
  • Susquehanna International Group first reported a position in DMK Pharmaceuticals Corporation Common Stock in Q2 2014 and held it in 36 quarters.
  • Susquehanna International Group's DMK Pharmaceuticals Corporation Common Stock position peaked at $2.16M in Q3 2018.
  • 3 funds tracked by Wall St. Rank held DMK Pharmaceuticals Corporation Common Stock as of Q1 2024.

Based on Susquehanna International Group's 13F filing for Q1 2024, filed 7 May 2024.